Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma
about
The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migrationMicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole bloodHuman protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the proteinCystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitorStructure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitorDifferential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineagesPhysical linkage of three CD3 genes on human chromosome 11The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix proteinFormation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cellsAnalysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell lineIdentification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus researchALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancerStatistical analysis of an RNA titration series evaluates microarray precision and sensitivity on a whole-array basisTwo newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cellsMolecular profiling of T-helper immune genes during dengue virus infectionStructures of Lysenin Reveal a Shared Evolutionary Origin for Pore-Forming Proteins And Its Mode of Sphingomyelin RecognitionStructural variants of human T200 glycoprotein (leukocyte-common antigen)The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytesAnti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastomaVariation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapySearching in mother nature for anti-cancer activity: anti-proliferative and pro-apoptotic effect elicited by green barley on leukemia/lymphoma cellsSphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 ActivationElimination of specific miRNAs by naked 14-nt sgRNAsCIN85 interacting proteins in B cells-specific role for SHIP-1.Herpes simplex virus requires VP11/12 to induce phosphorylation of the activation loop tyrosine (Y394) of the Src family kinase Lck in T lymphocytes.A phenotypic screening approach to identify anticancer compounds derived from marine fungi.Comparative assessment of methods for the computational inference of transcript isoform abundance from RNA-seq data.Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.Differential processing of small RNAs during endoplasmic reticulum stress.Transcription activator-like effector nuclease-mediated transduction of exogenous gene into IL2RG locusChromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcriptLineage specificity of gene expression patterns.American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells.Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation.Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAsZap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation.The Shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation.Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.A V(L) single-domain antibody library shows a high-propensity to yield non-aggregating binders.
P2860
Q21146664-B5ACBC0E-BF0A-45C8-9074-4EE59D7106DFQ21562182-1FFADBA7-68F3-4EEC-B698-D737AA496E00Q24308489-7571ADED-FDF0-44CB-ADD4-06035B23F56FQ24312357-A935DB85-A037-4DC8-9916-D32B8F5A74ACQ24315043-5AC24152-8F82-4878-B7BE-0DB9BD8506ADQ24319742-811B1557-2D80-4696-895F-8BA91101C8D5Q24556017-29D744AD-6AE3-4A7B-AF50-4EBB595ECFF4Q24556562-DF57612E-F3DB-48E5-9BD1-61EA3459A5BAQ24563634-9ECBCDAE-5B5B-4E83-A0F9-66FBBDE59BAFQ24567765-749E2F91-1FF8-48B8-91CF-CCAF7F85DB85Q24651042-A58CCDCC-782B-4905-AAD4-BD003217CFAEQ24672313-1D91404C-648B-4579-AEC1-5B63B3917911Q24678378-65FE7CE1-C829-4CE9-A656-CFC9EB51A4A9Q24685660-8CB908C5-44A0-45BD-A239-C93B3872BEFCQ27487753-DA7B1F9F-30CC-4431-8185-4742F94DE07AQ27670847-8CA55880-BD6A-400B-8F19-F9EC431A556AQ28115267-B3B4ED4B-7AFA-4673-B245-61E786C75324Q28287364-87F0E5C5-C2DE-4502-BCEB-7351736B9D5BQ28474789-3CECD7FA-42B7-47F0-B6CF-AFF016962716Q28534042-10ED1640-4F1D-41D2-9FEF-8B7B4F2EBE4DQ28536983-EEF8EAF1-F0FC-4956-82F9-ECA6A747CC9EQ28552969-76169A9A-ADB4-413C-9C53-F494D76C953EQ28728927-457247F8-48AD-408B-85CB-BC0CED1E5BABQ30010282-556D2758-FF56-4A4E-9DA7-63B1EE9FD8ACQ30157107-05C6D2B5-17A9-4A97-A3A8-7D726B3A6947Q30415131-6FC34ABF-6399-43C1-9F13-03EF132A41F9Q30982079-2357053A-6DBE-4027-AD67-9104E6509A4AQ33565239-9F34E1B4-76BF-4A69-B1F6-D79A5F37AE64Q33612455-71D3A439-4C1E-4162-85B1-F9CCD3699CE2Q33651871-5143A72C-F21E-486E-8F39-0F6B3A29E702Q33680724-41FC01C1-9F25-4323-AA42-D6C300F474B8Q33695334-F15DD946-ACEF-45D5-8E0D-9DAB323C8464Q33707992-DC4C4920-6978-4E60-BE14-1C555CA02A2AQ33728657-99B19C42-0C7B-43E8-AD0E-094FBC906604Q33819203-2B806660-F8E9-47B1-8570-41C5EBEA015EQ34012565-8712C3A3-D08B-4036-BF70-ECB48D1DC061Q34126548-91B81D43-344A-4BB2-97F6-F839536B20FCQ34140221-9C8B1794-49C6-4705-B743-6E786B965BBBQ34161866-98D8BAA6-82D1-4A99-A895-15116ABC0DA9Q34227317-277F2F0A-BB1D-43A9-830C-9B7877E65E1A
P2860
Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma
description
1977 nî lūn-bûn
@nan
1977 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@ast
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@en
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@nl
type
label
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@ast
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@en
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@nl
prefLabel
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@ast
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@en
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@nl
P2093
P3181
P356
P1476
Characterization of EBV-genome ...... ansformed non-Hodgkin lymphoma
@en
P2093
G Bornkamm
H U Schwenk
U Schneider
P3181
P356
10.1002/IJC.2910190505
P407
P577
1977-05-15T00:00:00Z